Advertisement
Advertise here Publish your press releases here Sponsor BioPortfolio
Follow us on Twitter Sign up for daily news and research emails Contributors wanted

Thrasos Innovation, Inc. Company Profile

08:48 EDT 23rd April 2014 | BioPortfolio

Thrasos is a private, clinical stage, bio-therapeutics Company focused on the discovery and development of targeted therapies for the prevention and treatment of severe organ failure, with a principle focus on kidney disease. The Company’s first drug candidates were selected from an extensive inventory of active peptide compounds generated by the Company’s design technology platform, called Structure Variant Analysis (SVA). Using SVA, Thrasos has pioneered the design of compounds based on the structure of the bone morphogenetic protein (BMP) family to activate the Smad transduction pathway. The resulting peptides have been shown to protect, repair and restore cell and tissue function in the kidney and other organs.


News Articles [311 Associated News Articles listed on BioPortfolio]

Thrasos, Inc. - Product Pipeline Review - 2013

Recently added to the BioPortfolio report store, Thrasos, Inc. - Product Pipeline Review - 2013 is a new report from Global Markets Direct published on 2013-10-30. This 26-page report is available in...

Europe loses Innovation League

Yesterday the European Commission published the results of the new Innovation Union scoreboard, which in terms of innovation compares member states to their closest competitors. These data show a gene...

Celebrating 2012′s High Innovation Quotient Deals

Innovation paid dividends in 2012.  We often debate the relative “innovation quotient” of the companies we evaluate and invest in here at Atlas, and of the biomedical sector as a whole. The basic...

EU Innovation Scoreboard Shows Need for Action to Keep Innovation and Industry in Europe

The 2014 EU Innovation Scoreboard published by the European Commission stressed that Europe risks becoming the world's research hub while innovative products and processes and the jobs and growth that...

PwC report-Medtech companies prepare for an innovation makeover

For decades, the medtech industry was on the forefront of innovation, but now return on innovation investment is declining. Growth through technology innovation has slowed substantially and the benefi...

The New Math Of Ortho Innovation – An Interview With Zimmer CEO David Dvorak

After emerging from the DOJ settlements, the leading pure-play orthopedics company is emphasizing – and redefining – innovation to drive growth. Zimmer CEO David Dvorak talks to IN VIVO about his...

Innovation Act Threatens Biotech Innovation

BIO has grave concerns regarding the Innovation Act (H.R. 3309), as reported by the House Judiciary Committee. The Innovation Act was introduced with the goal of furthering patent system reform, par...

Johnson & Johnson Innovation establishes network of partnering offices

Johnson & Johnson Innovation, London, has formed a network of partnering offices across U.K. life science clusters. The offices function as extensions of its London Innovation Center, to work with aca...

PubMed Articles [142 Associated PubMed Articles listed on BioPortfolio]

Surgical innovation, a niche and a need.

Clinicians' Contributions to the Development of Coronary Artery Stents: A Qualitative Study of Transformative Device Innovation.

Medical device innovation remains poorly understood, and policymakers disagree over how to incentivize early development. We sought to elucidate the components of transformative health care innovation...

Innovation in Safety, and Safety in Innovation.

Compulsory licensing and access to drugs.

Compulsory licensing allows the use of a patented invention without the owner's consent, with the aim of improving access to essential drugs. The pharmaceutical sector argues that, if broadly used, it...

The Optimal Licensing Contract in a Differentiated Stackelberg Model.

This paper extends the work of Wang (2002) by considering a differentiated Stackelberg model, when the leader firm is an inside innovator and licenses its new technology by three options, that is, fix...

Clinical Trials [10 Associated Clinical Trials listed on BioPortfolio]

Bipolar Research And Innovation Network - BRAIN

To describe the broad spectrum of Bipolar Disorder patients admitted to out-patient and in-patient psychiatric departments in Norway. Include all admitted Bipolar patients both with and wi...

Innovation in Pulmonary Rehabilitation

The purpose of this study is to compare the effect of exercise treatment combined with breathing retraining (a computerized feedback program), with exercise treatment combined with heliox...

Innovation-TiFP4-C101: A Study to Evaluate the Pharmacokinetics of TMC114 and TMC41629 After a Single Oral Dose of 2 Controlled-release Coformulations as Compared to an Immediate-release Coformulation of TMC114/TMC41629

The purpose of this study is to compare the bioavailability (the degree to which a drug becomes available in the body after administration) of 3 different pharmaceutical preparations of a...

Limitations of Using a Sheimpflug Image-Based Device for Measuring Anterior Chamber Depth in Pseudophakic Eyes

There have been numerous studies comparing various ACD measurements in phakic eyes,while researches comparing ACD in pseudophakic eyes are less extensive. With the recent popularity of pr...

A Pilot Scheme - Specimen Collection of Health Management Center

Biomedical and biotechnology industry is internationally regarded as the most brilliant star performer of the future. The development of biomedical depends on a high quality academic resea...

Companies [797 Associated Companies listed on BioPortfolio]

Thrasos Therapeutics

Thrasos TherapeuticsTM is a private, clinical stage, biotherapeutics company focused on the discovery and development of targeted therapies for the prevention and treatment of kid...

Thrasos Innovation, Inc.

Thrasos is a private, clinical stage, bio-therapeutics Company focused on the discovery and development of targeted therapies for the prevention and treatment of severe organ fail...

Thrasos, Inc.

Thrasos is a private, clinical stage, bio-therapeutics company focused on the discovery and development of targeted therapies for the prevention and treatment of kidney disease. T...

BIOTAQ INC

A privately funded biotech start-up We focus on developing cost effective, easy-to-use, re-generable, energy-saving, eco-friendly new tools, kits & reagents or providing unique services for life scien...

Council for American Medical Innovation (CAMI)

The United States faces serious challenges to maintaining its leadership position in innovation. The Council for American Medical Innovation is bringing together leaders in...

More Information about "Thrasos Innovation, Inc." on BioPortfolio

We have published hundreds of Thrasos Innovation, Inc. news stories on BioPortfolio along with dozens of Thrasos Innovation, Inc. Clinical Trials and PubMed Articles about Thrasos Innovation, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Thrasos Innovation, Inc. Companies in our database. You can also find out about relevant Thrasos Innovation, Inc. Drugs and Medications on this site too.

Search BioPortfolio:
Advertisement

Corporate Database Quicklinks



Searches Linking to this Company Record

Advertisement